Related Experiment Videos
Magnesium treatment for sudden hearing loss
Ben I Nageris1, David Ulanovski, Joseph Attias
1Department of Otolaryngology-Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel.
The Annals of Otology, Rhinology, and Laryngology
|August 28, 2004
Summary
Magnesium supplementation, alongside steroids, significantly improved hearing outcomes in patients with sudden sensorineural hearing loss. This treatment enhanced hearing recovery across all frequencies, particularly in the low-tone range.
Area of Science:
- Otolaryngology
- Neuroscience
- Pharmacology
Background:
- Noise-induced hearing loss is often mitigated by magnesium treatment.
- The potential of magnesium to improve hearing in acute-onset hearing loss remains under investigation.
Purpose of the Study:
- To investigate the efficacy of magnesium as an adjunct to steroid therapy for idiopathic sudden sensorineural hearing loss.
- To evaluate the impact of magnesium on hearing threshold shifts in patients with acute hearing loss.
Main Methods:
- A prospective, randomized, double-blind, placebo-controlled trial was conducted.
- 28 patients with idiopathic sudden sensorineural hearing loss were enrolled.
- Participants received either steroids plus oral magnesium or steroids plus a placebo.
Main Results:
- The magnesium-treated group showed a significantly higher proportion of patients with improved hearing (>10 dB) across all tested frequencies.
- A significantly greater mean improvement in hearing was observed in the magnesium group compared to the placebo group.
- Individual data analysis confirmed more substantial hearing improvements in magnitude and number of patients in the magnesium group.
Conclusions:
- Magnesium serves as a safe and effective adjunct to steroid treatment for sudden sensorineural hearing loss.
- Magnesium supplementation notably enhances hearing recovery, especially in the low-tone frequency range.
- The findings support the use of magnesium to improve audiological outcomes in sudden sensorineural hearing loss patients.